For the Inventor, By the Inventor

Enter assignee name

Lexington, MA, United States of America

Interneuron Pharmaceuticals, Inc.

USPTO Granted Patents = 15

Forward Citations = 182

Loading Chart...

Loading Chart...

23 inventors (with patents filed for the assignee):

Kenneth W Locke (8 out of 8 patents)

Richard J Wurtman (5 out of 69 patents)

Judith J Wurtman (3 out of 17 patents)

4. Marc Fisher (3 out of 3 patents)

5. Bobby W Sandage, Jr (2 out of 3 patents)

6. Kay Jorgenson D'Orlando (2 out of 6 patents)

7. Emile M Bellott (2 out of 12 patents)

8. Yesh P Sachdeva (2 out of 23 patents)

9. Richard L Gabriel (2 out of 17 patents)

10. Stuart Fielding (2 out of 3 patents)

11. Emile Al-Farhan (2 out of 8 patents)

12. Salah A Zahr (2 out of 10 patents)

13. Subramaniam Krishnananthan (2 out of 2 patents)

14. Michael D Nohrden (2 out of 2 patents)

15. Thomas Joel Zupancic (1 out of 17 patents)

15 patents: Sort by Forward Citations

1. 6451523 - Detection of a leptin receptor variant and methods for regulating obesity (2002-09-17),

2. 6057301 - Hyperhydrated citicoline, process and use (2000-05-02),

3. 5872108 - Reduction of infarct volume using citicoline (1999-02-16),

4. 5827832 - Method of protecting brain tissue from cerebral infarction subsequent to (1998-10-27),

5. 5801160 - Method of protecting brain tissue from cerebral infarction subsequent to (1998-09-01),

6. 5744476 - Dopamine D.sub.1 agonists for the treatment of dementia (1998-04-28),

7. 5698525 - Reducing post-prandial fluctuations in plasma concentrations of large (1997-12-16),

8. 5580878 - Substituted tryptamines phenalkylamines and related compounds (1996-12-03),

9. 5432162 - Reducing post-prandial fluctuations in plasma concentrations of large (1995-07-11),

10. 5403851 - Substituted tryptamines, phenalkylamines and related compounds (1995-04-04),

11. 5260091 - Salt taste enhancers (1993-11-09),

12. 5206218 - Reducing post-prandial fluctuations in plasma concentrations of large (1993-04-27),

13. 5206049 - Choline-containing compositions as salt substitutes and enhancers and a (1993-04-27),

14. 5096712 - Method for enhancing performance so as to improve vigor and decrease (1992-03-17),

15. 5019594 - Method for decreasing appetite (1991-05-28),

Company Overview

Interneuron Pharmaceuticals, Inc. is a biotechnology company based in Lexington, MA, specializing in the development of innovative therapies for neurological and psychiatric disorders. The organization focuses on advancing treatments that target unmet medical needs, leveraging its expertise in neuroscience and pharmacology. Through rigorous research and development, Interneuron aims to improve patient outcomes and enhance the quality of life for individuals affected by these conditions.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 20 2026

15 Patents

#46 in Lexington, MA

#1,276 in Massachusetts

#21,068 in US

#39,959 in the World

Lexington, MA, United States of America

Interneuron Pharmaceuticals, Inc.

Forward Citations = 182

23 inventors:

Kenneth W Locke (8 out of 8 patents)

Richard J Wurtman (5 out of 69 patents)

Judith J Wurtman (3 out of 17 patents)

4. Marc Fisher (3 out of 3 patents)

5. Bobby W Sandage, Jr (2 out of 3 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Interneuron Pharmaceuticals, Inc.. Retrieved from https://idiyas.com/company/interneuron-pharmaceuticals

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

Loading…